Thursday, March 25, 2021
5:00pm PT | 8:00pm ET | 9:00pm AT
International Expert: Toni Choueiri
Canadian KOL: Aly-Khan Lalani
1. Review recent advancements in systemic therapies for advanced RCC
2. Discuss key considerations that may assist in selecting among first line combinations
3. Highlight emerging targets and evolving clinical trial landscape for RCC patients
SERIES SPONSOR: Janssen
Specific Sponsors: Bristol Myers Squibb, Merck
Accredited for Section 1 Credits √
Questions? Contact Tal at the CUA - email@example.com
NOTE: For members who would like this activity recorded in their profile, please use the email that is associated with your CUA membership.
***This webinar is reserved for healthcare professionals and sponsoring companies.
Registration will be vetted before event links are provided to participants.***
Ce programme est disponible en anglais seulement.